Volver al buscador
FDAFDA · Alimentos y medicamentos·N.º oficial Z-2544-2024

Beckman Coulter DxI 9000 Access Immunoassay Analyzer, Catalog #C11137.

Publicado el 21 de agosto de 2024 · Inicio del retiro: 22 de mayo de 2024

Resumen

FDA registra el retiro Z-2544-2024 de dispositivos médicos de Clase II, publicado el 21 de agosto de 2024 e iniciado el 22 de mayo de 2024. Empresa responsable: Beckman Coulter, Inc.; Estado: En curso; Cantidad reportada: 183 devices; Lote: Software versions 1.17 and below, UDI-DI 15099590732103. La Clase II indica posibles consecuencias temporales o médicamente reversibles, o una probabilidad remota de consecuencias graves.

Estado reportado al momento de publicación: Ongoing — openFDA actualiza semanalmente y este campo no refleja el estado más reciente. Confirma siempre con la fuente oficial.

Qué peligro representa

The reason for this recall is Beckman Coulter has determined that when a DxI 9000 Access Immunoassay Analyzer is connected to a Laboratory Automation System (LAS); is running with the software versions 1.17 and below; and a sample tube is sent from the LAS to DxI 9000 Access Immunoassay Analyzer, an out of sequence message will be sent from the Analyzer to the LAS. This issue may result in multiple error messages (i.e., a sample pick and place (PnP) error or a no result obtained (NRT) flag may be displayed) and subsequently a risk of delays in processing/reporting patient test results and patient treatment.

Qué hacer

Voluntary: Firm initiated · Letter

Recibe un correo cuando FDA publique un retiro como este

Gratis. Solo te escribimos cuando hay un retiro nuevo que coincide. Te das de baja con un clic.

Detalles del retiro

Fabricante
Beckman Coulter, Inc.
Distribuidor
Worldwide distribution - US Nationwide distribution in the states of CA, FL, GA, IN, KS, ME, NH, NJ, OK, PA, and TX. The countries of Australia, Austria, Bahrain, Belgium, Brazil, Croatia, Czech Republic, Egypt, France, Germany, Hungary, Ireland, Israel, Italy, Netherlands, New Zealand, Poland, Portugal, Slovakia, South Africa, Spain, Switzerland, Taiwan, and United Kingdom.
Lote
Software versions 1.17 and below, UDI-DI 15099590732103.
Clasificación de riesgo
Class II
Área (FDA)
device
País
United States

Retiros relacionados

Preguntas sobre este retiro

¿Beckman Coulter DxI 9000 Access Immunoassay Analyzer, Catalog #C11137. fue retirado del mercado?

Sí. FDA publicó el retiro Z-2544-2024 el 21 de agosto de 2024. Peligro reportado: The reason for this recall is Beckman Coulter has determined that when a DxI 9000 Access Immunoassay Analyzer is connected to a Laboratory Automation System (LAS); is running with the software versions 1.17 and below; and a sample tube is sent from the LAS to DxI 9000 Access Immunoassay Analyzer, an out of sequence message will be sent from the Analyzer to the LAS. This issue may result in multiple error messages (i.e., a sample pick and place (PnP) error or a no result obtained (NRT) flag may be displayed) and subsequently a risk of delays in processing/reporting patient test results and patient treatment.

¿Qué debo hacer si tengo este producto?

Voluntary: Firm initiated · Letter